ZBH vs SOLV — Key Metrics
| Metric | ZBH (ZIMMER BIOMET HOLDINGS INC) | SOLV (SOLVENTUM CORP) |
|---|---|---|
| Price | 88.83 | 88.15 |
| Market Cap | 16.94 Billion | 15.01 Billion |
| P/E (TTM) | 21.51 | 10.72 |
| P/B (Quarterly) | 1.483 | 3.102 |
| P/S (TTM) | 1.99 | 1.81 |
| Net Profit Margin (TTM) | 9.5 | 17.3 |
| Gross Margin (TTM) | 69.9 | 54.7 |
| ROE (TTM) | 6.4 | 29.0 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
ZBH · ZIMMER BIOMET HOLDINGS INC
Underperform
SOLV · SOLVENTUM CORP
Outperform
Recommendation Summary
Stock ZBH is projected to underperform the market, stock SOLV is projected to outperform the market. Upfront Recommendation: SOLV.
Financial Metrics
Prices delayed ~15 min
| ZBH | Metrics | SOLV |
|---|---|---|
| $88.83 | Price | $88.15 |
| — | Market Capitalization | — |
| 21.51 | Price to Earnings Ratio | 10.72 |
| 1.99 | Price to Sales | 1.81 |
| 2.85 | Price to Gross Profit | 3.3 |
| 38.26 | Price to R&D | 20.7 |
| 3.32 | Price to Current Assets | 4.01 |